Respiratory syncytial virus (RSV) is a highly contagious and seasonal respiratory virus that mainly causes common cold symptoms in healthy adults but can cause more serious lung infections in infants, the immunocompromised ...
May 24, 2023
0
29
New research suggests that the molecular clock, derived from time-keeping genes in our cells, enables us to modify how we breathe over the day. Researchers from Marquette University in Wisconsin determined that mice without ...
May 23, 2023
0
2
Chronic respiratory diseases (CRDs) were the third leading cause of death globally, accounting for 4.0 million deaths in 2019, according to a study published online April 25 in eClinicalMedicine.
May 18, 2023
0
25
Experts have called for further scrutiny of a new Pfizer vaccine given during pregnancy to prevent respiratory infection in infants, after trials of a similar GSK vaccine were stopped after a rise in preterm birth and infant ...
May 10, 2023
0
54
Globally, air pollution is a major public health hazard. A key air pollutant linked to health risks is ambient fine particulate matter (PM2.5), which consists of minute particles, sized less than or equal to 2.5 μm, suspended ...
May 8, 2023
0
4
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.
May 3, 2023
0
10
A key mechanism of cadmium-linked inflammation that increases severity and mortality of lung infections has been described, offering a promising therapeutic target to limit lung injury and death.
Apr 20, 2023
0
15
While COVID-19 rates in the U.S. are relatively low and are declining, The World Health Organization is keeping an eye on a new COVID-19 variant. The omicron subvariant XBB.1.16, known as "Arcturus," has been listed by the ...
Apr 14, 2023
0
4
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop ...
Apr 13, 2023
0
26
